Immune responses against different variants of SARS-CoV-2 including Omicron following 6 months of administration of heterologous prime-boost COVID-19 vaccine.
J Travel Med
; 29(3)2022 05 31.
Article
in En
| MEDLINE
| ID: mdl-35244698
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
COVID-19
Limits:
Humans
Language:
En
Journal:
J Travel Med
Journal subject:
DOENCAS TRANSMISSIVEIS
/
SAUDE PUBLICA
Year:
2022
Document type:
Article
Affiliation country:
India